middle.news
Paradigm Completes Phase 3 Recruitment and Raises A$21.74m
12:47pm on Friday 28th of August, 2026 AEST
•
Healthcare
Read Story
Paradigm Completes Phase 3 Recruitment and Raises A$21.74m
12:47pm on Friday 28th of August, 2026 AEST
Key Points
538 patients enrolled in global Phase 3 trial, exceeding target
Raised A$21.74 million via placement and share purchase plan
Net loss widens to $56.3 million due to trial expenses
Upcoming interim analysis and primary endpoint readout
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Paradigm Biopharmaceuticals (ASX:PAR)
OPEN ARTICLE